Pramlintide
Back to searchMolecule Structure
Scientific Name
Pramlintide
Description of the Drug
Pramlintide is an amylin analog used for the management of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01278
http://www.drugbank.ca/drugs/DB01278
Brand Name(s)
Not Available
Company Owner(s)
Astrazeneca Ab
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Amylin receptor AMY2; CALCR/RAMP2 | PROTEIN COMPLEX | AGONIST | CHEMBL2364173 |
Amylin receptor AMY1, CALCR/RAMP1 | PROTEIN COMPLEX | AGONIST | CHEMBL2111189 |
Amylin receptor AMY3; CALCR/RAMP3 | PROTEIN COMPLEX | AGONIST | CHEMBL2111190 |
Clinical Trial(s)
Unichem Links
DrugBank | DB01278 | ||
PubChem | 126456229 | 137699448 | 70691388 |
DrugCentral | 2236 | ||
rxnorm | PRAMLINTIDE ACETATE | SYMLIN | PRAMLINTIDE |
ChEBI | 135922 |